Atlas Trials

Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors

Clinical trial NCT00880308 · COMPLETED

Trial details

NCT number
NCT00880308
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid Tumor CancersMedulloblastomaBasal Cell Carcinoma
Start date
2009-03-01
Primary completion
2013-07-01
Enrollment
103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.